Cargando…

Deregulated Serotonin Pathway in Women with Morbid Obesity and NAFLD

Non-alcoholic fatty liver disease (NAFLD) extends from simple steatosis (SS) to non-alcoholic steatohepatitis (NASH). Peripheral serotonin (5-HT) has become as an important regulator of different metabolic pathways. 5-HT has been related to obesity and lipid accumulation in the liver. The objective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Binetti, Jessica, Bertran, Laia, Riesco, David, Aguilar, Carmen, Martínez, Salomé, Sabench, Fàtima, Porras, Jose Antonio, Camaron, Javier, Castillo, Daniel Del, Richart, Cristóbal, Auguet, Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603041/ https://www.ncbi.nlm.nih.gov/pubmed/33081272 http://dx.doi.org/10.3390/life10100245

Ejemplares similares

Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis
por: Auguet, Teresa, et al.
Publicado: (2020)

Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity
por: Bertran, Laia, et al.
Publicado: (2021)

Expression of Jejunal Taste Receptors in Women with Morbid Obesity
por: Bertran, Laia, et al.
Publicado: (2021)

Circulating Levels of Pro-Neurotensin and Its Relationship with Nonalcoholic Steatohepatitis and Hepatic Lipid Metabolism
por: Villar, Beatriz, et al.
Publicado: (2021)

The Potential Protective Role of RUNX1 in Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2021)

Expression of STING in Women with Morbid Obesity and Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2023)

Hepcidin in morbidly obese women with non-alcoholic fatty liver disease
por: Auguet, Teresa, et al.
Publicado: (2017)

The Role of Olfactomedin 2 in the Adipose Tissue–Liver Axis and Its Implication in Obesity-Associated Nonalcoholic Fatty Liver Disease
por: Barrientos-Riosalido, Andrea, et al.
Publicado: (2023)

LC/MS-Based Untargeted Metabolomics Study in Women with Nonalcoholic Steatohepatitis Associated with Morbid Obesity
por: Bertran, Laia, et al.
Publicado: (2023)

LC/MS-Based Untargeted Metabolomics Analysis in Women with Morbid Obesity and Associated Type 2 Diabetes Mellitus
por: Auguet, Teresa, et al.
Publicado: (2023)

Increased Hepatic ATG7 mRNA and ATG7 Protein Expression in Nonalcoholic Steatohepatitis Associated with Obesity
por: Barrientos-Riosalido, Andrea, et al.
Publicado: (2023)

Increased Secreted Frizzled-Related Protein 5 mRNA Expression in the Adipose Tissue of Women with Nonalcoholic Fatty Liver Disease Associated with Obesity
por: Bertran, Laia, et al.
Publicado: (2022)

New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2022)

New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women
por: Auguet, Teresa, et al.
Publicado: (2011)

Altered Fatty Acid Metabolism-Related Gene Expression in Liver from Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2014)

Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2014)

PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2016)

Interleukin-17A Gene Expression in Morbidly Obese Women
por: Zapata-Gonzalez, Fernando, et al.
Publicado: (2015)

Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2016)

Are Ingested or Inhaled Microplastics Involved in Nonalcoholic Fatty Liver Disease?
por: Auguet, Teresa, et al.
Publicado: (2022)

miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2016)

Identification of the Potential Molecular Mechanisms Linking RUNX1 Activity with Nonalcoholic Fatty Liver Disease, by Means of Systems Biology
por: Bertran, Laia, et al.
Publicado: (2022)

Downregulation of de Novo Fatty Acid Synthesis in Subcutaneous Adipose Tissue of Moderately Obese Women
por: Guiu-Jurado, Esther, et al.
Publicado: (2015)

Predictive Biomarkers of COVID-19 Severity in SARS-CoV-2 Infected Patients with Obesity and Metabolic Syndrome
por: Perpiñan, Carles, et al.
Publicado: (2021)

Clinical and Biomarker Profile Responses to Rehabilitation Treatment in Patients with Long COVID Characterized by Chronic Fatigue
por: Binetti, Jessica, et al.
Publicado: (2023)

Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2019)

Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome
por: Perpiñan, Carles, et al.
Publicado: (2022)

Targeted metabolomic approach in men with carotid plaque
por: Auguet, Teresa, et al.
Publicado: (2018)

Adipo/cytokines in atherosclerotic secretomes: increased visfatin levels in unstable carotid plaque
por: Auguet, Teresa, et al.
Publicado: (2016)

Quantitative and Topographic Analysis by Immunohistochemical Expression of Ghrelin Gastric Cells in Patients with Morbid Obesity
por: Parada D, David, et al.
Publicado: (2020)

Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients
por: Kälsch, Julia, et al.
Publicado: (2011)

Depression and Antidepressants During Pregnancy: Craniofacial Defects Due to Stem/Progenitor Cell Deregulation Mediated by Serotonin
por: Sánchez, Natalia, et al.
Publicado: (2021)

Pharmacogenetics of Efficacy and Safety of HCV Treatment in HCV-HIV Coinfected Patients: Significant Associations with IL28B and SOCS3 Gene Variants
por: Vidal, Francesc, et al.
Publicado: (2012)

Molecular pathways in non-alcoholic fatty liver disease
por: Berlanga, Alba, et al.
Publicado: (2014)

Baseline Presence of NAFLD Predicts Weight Loss after Gastric Bypass Surgery for Morbid Obesity
por: Rheinwalt, Karl Peter, et al.
Publicado: (2020)

Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
por: Jeong, Seogsong, et al.
Publicado: (2023)

Prevalence of NAFLD in Healthy and Young Male Individuals
por: Niaz, Asif, et al.
Publicado: (2011)

Schizophrenia and depression, two poles of endocannabinoid system deregulation
por: Rodríguez-Muñoz, María, et al.
Publicado: (2017)

Chromatin deregulation in disease
por: Mirabella, Anne C., et al.
Publicado: (2015)

Molecular Mechanisms of NAFLD in Metabolic Syndrome
por: Martins, Maria João, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ma4n5k6ld8uuub35pifts3qhfd